Trial site
Ivanovo regional oncology dispensary
Ivanovo, 153040, RussiaNot linked to an institution yet
- 8running trials
- 5closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Phase
- Phase 311 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Active, not recruiting8 trials
- Completed4 trials
- Terminated1 trial
- Lead sponsor
- Janssen Research & Development, LLC4 trials
- Hoffmann-La Roche2 trials
- Bayer1 trial
- Bristol-Myers Squibb1 trial
- Hinova Pharmaceuticals USA, Inc.1 trial
- and 4 more
Running trials
Active, not recruiting
A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer
NCT07553988· Phase 2· R-Pharm International, LLC· Source
Active, not recruiting
A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread
NCT04810078· Phase 3· Bristol-Myers Squibb· Source
Active, not recruiting
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT04691804· Phase 3· Jiangsu HengRui Medicine Co., Ltd.· Source
Active, not recruiting
A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder
NCT04658862· Phase 3· Janssen Research & Development, LLC· Source
Active, not recruiting
A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer
NCT04557059· Phase 3· Janssen Pharmaceutica N.V., Belgium· Source
Active, not recruiting
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)
NCT04497844· Phase 3· Janssen Research & Development, LLC· Source
Active, not recruiting
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
NCT03748641· Phase 3· Janssen Research & Development, LLC· Source
Active, not recruiting
A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer
NCT03473743· Phase 1/2· Janssen Research & Development, LLC· Source
Report an error